TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

TG Therapeutics had revenue of $141.15M in the quarter ending June 30, 2025, with 92.13% growth. This brings the company's revenue in the last twelve months to $454.07M, up 30.96% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.

• Revenue (ttm): $454.07M
• Revenue Growth: +30.96%
• P/S Ratio: 8.96
• Revenue / Employee: $1,343,399
• Employees: 338
• Market Cap: 4.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.